Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer Who Will be Treated With Anthracyclines

NCT03027063 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03027063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03027063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer Who Will be Treated With Anthracyclines
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
October 31, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adriamycin toxicity, breast cancer female